Pages that link to "Q67755342"

The following pages link to Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity (Q67755342):

Displaying 39 items.

• Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma (Q33704212) (← links)
• Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (Q34408350) (← links)
• Assessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro (Q34555868) (← links)
• Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer (Q34779799) (← links)
• PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma (Q35116765) (← links)
• Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer (Q35131272) (← links)
• Functional imaging techniques for evaluation of sarcomas (Q35172979) (← links)
• PET Scans in the Staging of Lymphoma: Current Status (Q35552612) (← links)
• PET in lymphoma (Q35650641) (← links)
• Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations (Q35753798) (← links)
• The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma (Q35862357) (← links)
• Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node (Q36537056) (← links)
• Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients (Q36618126) (← links)
• Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas (Q36621241) (← links)
• Sigma-2 receptors as a biomarker of proliferation in solid tumours (Q36621308) (← links)
• FDG-PET. A possible prognostic factor in head and neck cancer (Q36644134) (← links)
• Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. (Q37140996) (← links)
• Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma (Q37220967) (← links)
• ⁹⁹mTc-N4amG: synthesis biodistribution and imaging in breast tumor-bearing rodents (Q37436095) (← links)
• Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy (Q38762740) (← links)
• Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma (Q40964770) (← links)
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose (Q41224253) (← links)
• Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? (Q41486823) (← links)
• Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas (Q41679888) (← links)
• Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma (Q43263556) (← links)
• (99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals (Q46678374) (← links)
• FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma (Q46807605) (← links)
• Synthesis of 2-[18F]Fluoro-2-deoxy-l-dlucose and positron emission tomography studies in monkeys (Q48124922) (← links)
• Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung Cancer (Q53235529) (← links)
• DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer. (Q55506344) (← links)
• Diagnostic value of software-based image fusion of computed tomography and F18-FDG PET scans in patients with malignant lymphoma (Q57649798) (← links)
• Non-Hodgkin Lymphoma Metabolism (Q60628572) (← links)
• A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma (Q71518845) (← links)
• FDG-PET for the evaluation of tumor viability after anticancer therapy (Q72160055) (← links)
• Can nuclear medicine predict response to chemotherapy? (Q72257322) (← links)
• FDG-PET for predicting the prognosis of malignant lymphoma (Q72385122) (← links)
• FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models (Q73537175) (← links)
• FDG PET characterization of renal masses: Preliminary experience (Q73551869) (← links)
• Prognostic value of quantitative FDG-PET in the prediction of survival and local recurrence for patients with advanced oral cancer treated with superselective intra-arterial chemoradiotherapy (Q94552579) (← links)